Wake Forest University (WFU) Institutional Biosafety Committee (IBC) provides local review and oversight of nearly all research involving recombinant or synthetic nucleic acid molecules (r/sNA) conducted at or sponsored by the University. The Committee approves the research projects that comply with the National Institute of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nuclei Acid Molecules. Furthermore, the IBC is typically assigned to review and approve research involving:
- Select agents and toxins
- Microorganisms and viruses pathogenic to humans, plant or animals
- Biological material from human and non-human primates
- Stem cell research and nanotechnology
- “Dual Use” research
- Animal tissues that present zoonotic disease concerns
The IBC reports to the Provost.